Dr Lal PathLabs Q4 results beat estimates, declares ₹6 final
Shares of Dr Lal PathLabs were trading 5.3% higher at ₹2934.25 on the BSE after the results were announced.
Source
<meta name="google-adsense-account" content="ca-pub-6363428395369086">
- Global markets mixed ahead of Fed decision amid trade tensions,
- WAVES Summit 2025: Shah Rukh Khan kicks off 4-day event